Literature DB >> 21765295

Urinary bladder masses: techniques, imaging spectrum, and staging.

Manjiri K Dighe1, Puneet Bhargava, Jonathan Wright.   

Abstract

Bladder carcinoma is the fourth most common cancer in men and women. Knowledge of imaging options and appearance is necessary for both radiologists and urologists. Transitional cell carcinoma is the most common bladder neoplasm with squamous cell and adenocarcinoma found in less than 10% of cases. Benign lesions are uncommon, but some can be suggested by their imaging appearance. Similarly, malignant lesions often have suggestive appearance and/or location. Cystoscopy allows tissue diagnosis and treatment of superficial lesions. Although magnetic resonance imaging (MRI) and computed tomography (CT) both have limitations in detailing depth of muscle invasion, both have a prominent role helping to define the lesion and in staging. This article illustrates the role of MRI and CT in evaluating bladder masses with a discussion of the newer techniques of MR diffusion-weighted imaging and virtual cystoscopy by CT or MRI. This article reviews the multiple benign and malignant lesions of the bladder so that the reader can appreciate the role of cystoscopy, CT, MRI, diffusion-weighted imaging, and virtual cystoscopy in dealing with these relatively common tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21765295     DOI: 10.1097/RCT.0b013e31821c2e9d

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  [Dysuria and unclear lesional mass in the bladder].

Authors:  T Baum; K Holzapfel; D Münzel; E J Rummeny; J Gaa
Journal:  Radiologe       Date:  2014-01       Impact factor: 0.635

Review 2.  [The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].

Authors:  V Hechler; M Rink; D Beyersdorff; M Beer; A J Beer; V Panebianco; M Pecoraro; C Bolenz; G Salomon
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

3.  Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.

Authors:  Dae Hyeon Kwon; Phil Hyun Song; Hyun Tae Kim
Journal:  Korean J Urol       Date:  2012-07-19

4.  Urologic manifestations of inflammatory pseudotumor: Report of 2 cases and review of the literature.

Authors:  Nitin P Ghonge; Disha Mittal; Sudhir Jain; Bharat Aggarwal; Mariam Moshiri; Chandana Lall; Puneet Bhargava
Journal:  Radiol Case Rep       Date:  2015-12-07

5.  Computed tomography urography with corticomedullary phase can exclude urinary bladder cancer with high accuracy.

Authors:  Suleiman Abuhasanein; Carl Hansen; Dragan Vojinovic; Staffan Jahnson; Henrik Leonhardt; Henrik Kjölhede
Journal:  BMC Urol       Date:  2022-04-12       Impact factor: 2.264

6.  Real-time bladder lesion registration and navigation: a phantom study.

Authors:  Michelle Agenant; Herke-Jan Noordmans; Wim Koomen; J L H Ruud Bosch
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.